Athletics

Triple jumper cleared of wrongdoing in clenbuterol case

2018-09-27 23:06
Will Claye
Will Claye (Getty Images)

Los Angeles - Three-time Olympic medalist Will Claye has been cleared of wrongdoing after the US Anti-Doping Agency concluded trace amounts of clenbuterol in a urine sample were likely caused by his consumption of contaminated meat.

"USADA concluded that it was unlikely that the presence of clenbuterol in the athlete's sample resulted from a source other than contaminated meat consumed in Mexico," the Colorado-based body said in a statement issued on Thursday.

Claye, winner of triple jump silver medals at the 2012 and 2016 Olympics and long jump bronze in 2012, showed the small amounts of banned clenbuterol in an out-of-competition sample provided on August 1.

Clenbuterol is an anabolic agent prohibited at all times under global anti-doping rules.

However, USADA said it had investigated the circumstances of Claye's case, reviewing his whereabouts, dietary habits and lab reports that indicated "very low parts per billion concentrations" of the substance in his sample.

As a result of the finding, Claye will not face a ban. Since the sample was provided out of competition he will not forfeit any competitive results.

Read more on:    athletics
NEXT ON SPORT24X

What To Read Next

 

Read News24’s Comments Policy

Live Video Streaming
Video Highlights

Live scoring

 
 
Men
Women
Love 2 Meet
Sport24 on Twitter

Follow Sport24 news on Twitter

Featured

The 2018/19 Absa Premiership season is in full swing. Will Mamelodi Sundowns retain their title? Or can one of Kaizer Chiefs, Orlando Pirates, Wits, SuperSport United - or another team perhaps - snatch glory from the Brazilians? Be sure to visit Sport24 for all the latest news!

Latest blogs
Vote

How much of a runner are you?

Twitter Follow Sport24 on Twitter

Facebook "Like" Sport24's Facebook page

WIN Enter and win with Sport24!

BlackBerry Stay in the loop on your BlackBerry

RSS Feeds Sport news delivered really simply.

 
There are new stories on the homepage. Click here to see them.